Detalhe da pesquisa
1.
High Risk of New HPV Infection Acquisition Among Unvaccinated Young Men.
J Infect Dis
; 229(3): 707-718, 2024 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38012959
2.
Anogenital Human Papillomavirus (HPV) Infection, Seroprevalence, and Risk Factors for HPV Seropositivity Among Sexually Active Men Enrolled in a Global HPV Vaccine Trial.
Clin Infect Dis
; 74(7): 1247-1256, 2022 04 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34265048
3.
Nine-valent HPV vaccine efficacy against related diseases and definitive therapy: comparison with historic placebo population.
Gynecol Oncol
; 154(1): 110-117, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30982556
4.
Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial.
Lancet
; 390(10108): 2143-2159, 2017 Nov 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28886907
5.
A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women.
N Engl J Med
; 372(8): 711-23, 2015 Feb 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-25693011
6.
Immunogenicity of the 9-Valent HPV Vaccine Using 2-Dose Regimens in Girls and Boys vs a 3-Dose Regimen in Women.
JAMA
; 316(22): 2411-2421, 2016 12 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-27893068
7.
A seamless phase IIB/III adaptive outcome trial: design rationale and implementation challenges.
Clin Trials
; 12(1): 84-90, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25278227
8.
A 9-Valent HPV Vaccine in Women.
N Engl J Med
; 372(26): 2568-9, 2015 06 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-26107058
9.
Development and Validation of Two Optimized Multiplexed Serologic Assays for the 9-Valent Human Papillomavirus Vaccine Types.
mSphere
; 8(2): e0096221, 2023 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36926984
10.
Ten-Year Follow-up of 9-Valent Human Papillomavirus Vaccine: Immunogenicity, Effectiveness, and Safety.
Pediatrics
; 152(4)2023 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37667847
11.
Electroporation enhances immunogenicity of a DNA vaccine expressing woodchuck hepatitis virus surface antigen in woodchucks.
J Virol
; 85(10): 4853-62, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21389124
12.
Modeling the health and economic implications of adopting a 1-dose 9-valent human papillomavirus vaccination regimen in a high-income country setting: An analysis in the United Kingdom.
Vaccine
; 40(14): 2173-2183, 2022 03 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35232593
13.
Immunogenicity and safety of quadrivalent and 9-valent human papillomavirus vaccines in Indian clinical trial participants.
Hum Vaccin Immunother
; 18(6): 2105067, 2022 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35997582
14.
Human papillomavirus seroprevalence and seroconversion following baseline detection of nine human papillomavirus types in young women.
Tumour Virus Res
; 13: 200236, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35525430
15.
Immunogenicity and safety of the 9-valent human papillomavirus vaccine in Chinese females 9-45 years of age: A phase 3 open-label study.
Vaccine
; 40(23): 3263-3271, 2022 05 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35487814
16.
Real-world impact and effectiveness of the quadrivalent HPV vaccine: an updated systematic literature review.
Expert Rev Vaccines
; 21(12): 1799-1817, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36178094
17.
Design of a phase III efficacy, immunogenicity, and safety study of 9-valent human papillomavirus vaccine in prevention of oral persistent infection in men.
Contemp Clin Trials
; 115: 106592, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34678491
18.
Effectiveness, immunogenicity, and safety of the quadrivalent HPV vaccine in women and men aged 27-45 years.
Hum Vaccin Immunother
; 18(5): 2078626, 2022 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35853188
19.
Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial.
Lancet Infect Dis
; 22(3): 413-425, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34780705
20.
Additional Protection from 9-Valent HPV Vaccine if Administered Before HPV Exposure.
Am Fam Physician
; 93(4): 254-6, 2016 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26926809